Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Business Insights | The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities

The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities

Cardiovascular diseases and metabolic disorders are the most common groups of disease in Eastern Europe. Moreover, poor housing standards have exacerbated the spread of communicable diseases such as tuberculosis, diphtheria and cholera. In Eastern European countries, the rising expenditure on prescription pharmaceuticals is the leading contributor to increasing pressure on healthcare finances, and has therefore been a major catalyst for healthcare reforms. The Eastern European Pharmaceutical Market Outlook to 2014 provides a comprehensive coverage of the Eastern European pharmaceutical market, reviewing the market structure, pricing and regulation and includes detailed epidemiological analyses of the common indications. This report makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market share data, sales forecast and competitive landscape for the major players in Eastern European market.

Published: June 2009 - Eastern Europe.
Table of Contents
Price: $3,835.00 / €2,565.62

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions